Nabi Biopharmaceuticals Announces Fourth Quarter and Full-Year 2008 Financial Results

March 12, 2009 |

1 min read

ROCKVILLE, Md., March 11, 2009 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) today announced fourth quarter and year-end financial results for the three and twelve month periods ended December 27, 2008.

Earnings

MORE ON THIS TOPIC

Vaccines

Pfizer CEO Blasts HHS’ Anti-Vaccine Policies as Revenue Outlook Dims

December 16, 2025

·

3 min read

·

Annalee Armstrong

Contemporary art collage. Purple hand holding fan of dollar bills against bright yellow background. stock photo

Venture capital

Ambros Launches With $125M To Bring Italian Non-Opioid Pain Drug to America

December 16, 2025

·

1 min read

·

Annalee Armstrong

Illustration of businessman running back around

Autoimmune disease

Sanofi Taps Dren Again in up to $1.7B Autoimmune Partnership

December 15, 2025

·

1 min read

·

Annalee Armstrong

Rheumatoid arthritis (RA) commonly causes inflammation in the hands, leading to pain, swelling, and stiffness in the joints, particularly the small joints of the fingers and wrists. This inflammation results from the immune system attacking the body's own joint tissues, causing the synovium (lining of the joint) to become inflamed and release chemicals that damage nearby tissues.

Mergers & acquisitions

Sobi Makes $1.5B Gout Play With Arthrosi Acquisition

December 15, 2025

·

2 min read

·

Tristan Manalac